Colon Cancer, Multiple Myeloma Drug Development Highlights Week in Specialty Pharmacy

Top stories of the week on Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/colon-cancer-multiple-myeloma-drug-development-hig" target="_blank">View the story "Colon Cancer, Multiple Myeloma Drug Development Highlights Week in Specialty Pharmacy" on Storify</a>]

Related Content:

Specialty PharmacyOncology
FDA Grants Orphan Drug Designation to Alrizomadlin for Stage IIB-IV Melanoma
MicroRNA, AXL Gene Potentially Responsible for Drug Resistance in Certain Non-Small Cell Lung Cancers
Affordable Care Act Reduces Financial Barriers for Younger Cancer Survivors